As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...

New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes ...

It’s scary to think that we may have been using a surrogate — BMI — that may not have been all that accurate over the years," ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

FAMILY doctors should ask if patients are secretly using fat jabs, experts say. People with symptoms such as dizziness or gut pain could be suffering side effects from the drugs or have a separate ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Detailed Phase IIIb STEP UP trial results presented at the 2025 ADA Scientific Sessions found that an investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

"These treatments are only available on the NHS under strict criteria, and access will be through specialist NHS weight ...

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...